Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Remdesivir Approved by FDA Experimental Antiviral Oct/15/2020 Oct/24/2020 0
Apilimod Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020 Aug/26/2020 0
Hanfangchin A Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
Elopiprazole Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
MLN-3897 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
KW-8232 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
DS-6930 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
N-tert-Butylisoquine Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
ONO 5334 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
AMG-2674 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0